EP2199801A3

Biomarkers for early detection of ovarian cancer

Abstract

The present invention relates to a method of screening for ovarian cancer in a subject comprising: (a) measuring at least three biomarkers in a test serum sample of the subject, wherein said at least three biomarkers include transthyretin, apolipoprotein Al (ApoAl) and transferring; and (b) comparing the measured at least three biomarkers of the test serum sample to a measurement of the three biomarkers in a normal serum sample, wherein a decrease in the measured three biomarkers of the test serum sample compared to the measurement of the three biomarkers in the normal serum sample is indicative of ovarian neoplasia.

Term

Term ended

Projected expiry passed 14 July 2025, 1.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
US2003027216A1CitesUnited States of AmericaASearch report1-22
WO2004012588A2CitesWorld Intellectual Property Organization (WIPO)ASearch report1-22
ZHANG ZHEN ET AL: "Protein identification and immunoassay evaluation of a panel of biomarkers discovered through proteomic profiling for the detection of ovarian cancer", PROCEEDINGS OF THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 45, 1 March 2004 (2004-03-01), pages 242, XP002485511, ISSN: 0197-016XNon-patent––Search report–
TOSNER J ET AL: "SERUM PREALBUMIN, TRANSFERIN AND ALPHA-1-ACID GLYCOPROTEIN IN PATIENTS WITH GYNECOLOGICAL CARCINOMAS", NEOPLASMA, SCIENCES, vol. 35, no. 4, 1 January 1988 (1988-01-01), pages 403 - 412, XP008056610, ISSN: 0028-2685Non-patent––Search report–
KOZAK K R ET AL: "CHARACTERIZATION OF SERUM BIOMAKERS FOR DETECTION OF EARLY STAGE OVARIAN CANCER", PROTEOMICS, WILEY - VCH VERLAG, WEINHEIM, DE LNKD- DOI:10.1002/PMIC.200500093, vol. 5, no. 17, 1 November 2005 (2005-11-01), pages 4589 - 4596, XP008056606, ISSN: 1615-9853Non-patent––Search report–